Based upon a peculiar histopathological pattern showing elevated levels of COX-1 (not COX-2) in the epithelial compartment of ovarian tumor tissue undergoing extensive angiogenesis, the pharmacological action of SC-560 in ovarian cancer models was first investigated by Gupta R.A. et al. [104]. This evidence concerns the gene PTGS2 and ovarian carcinoma.